APPLICATION
ANDA206271
TYPE
ANDA
ORIGINAL APPROVAL
2015-11-09
LATEST ACTION
2019-08-21
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
NEVIRAPINEDiscontinued
NEVIRAPINE 100MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2019-08-21Labeling · Supplement 5 · standardAP
2019-08-21Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.